Last Transcript: Monogram Technologies Inc.

3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap. Importance
07/10/25 Issuer sale

Chief Financial Officer

411,385 1.0125%
07/10/25 Issuer sale

Chief Executive Officer

5,566,330 13.6993%
07/10/25 Issuer sale

Director

40,000 0.0984%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--% - - 244M
+0.20%+5.31%-18.40%+9.76% 181B
-0.73%+7.09%-1.08%+30.33% 116B
+0.49%+6.25%-21.30%+9.06% 113B
+3.83%+5.50%-50.59%-5.64% 79.83B
-0.14%+5.27%+5.00%+79.86% 65.06B
+0.62%+1.92%+14.24%+75.57% 54.35B
-1.04%+4.35%+1.40%-26.08% 52.23B
+2.41%+8.18%-11.81%+31.75% 44.15B
-1.90%+2.29%+29.19%+2.28% 32.47B
Average +0.19%+5.18%-5.93%+22.99% 82.07B
Weighted average by Cap. +0.44%+5.50%-11.25%+20.69%
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
-
  1. Stock Market
  2. Stocks
  3. MGRM Stock